Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fmc australasia pty ltd - iprodione; liquid hydrocarbon - emulsion - oil in water - iprodione carbamate active 250.0 g/l; liquid hydrocarbon solvent other 332.0 g/l - fungicide - almond | apricot | boysenberry | canola | celery | cherry | grape | kiwi fruit | lettuce | lucerne | macadamia | mandarin (non-b - alternaria leaf blight or spot blight | black leaf blight | blossom blight - botrytis spp. | blossom blight - monilinia laxa | botrytis | brown rot - monilinia spp. | brown rot - sclerotinia spp. | brown spot on mandarin | early blight or target blackspot | grey mould - botrytis cinerea | hypocotyl rot on potato | lucerne leaf spot | pepper scorch or spot | sclerotinia dropcollar rot of lettuce | sclerotinia rot on peanut | sclerotinia wilt or stem rot | alternaria leaf spot | alternata spot | black scurf | blossom blight | botrytis blight | botrytis rot | brown rot | brown spot | bunch rot | bunch rot-grey mould | grey mould | grey mould (nesting) | leaf spot - alternaria spp. | leptosphaerulina leaf spot | pink rot | post-harvest rot | sclerotinia nest | sclerotinia rot | storage rot | target spot | watery soft rot | white mould

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fmc australasia pty ltd - cypermethrin; flutriafol; ethylene glycol - liquid - cypermethrin pyrethroid active 4.0 g/l; flutriafol triazole active 25.0 g/l; ethylene glycol solvent other 495.0 g/l - mixed function seed treat - barley - seed | oats - seed | triticale seed | wheat - seed - cereal bunt | covered stinking smut | flag smut on cereal | granary weevil | lesser grain borer | loose smut - ustilago avenae | rice weevil | rust-red flour beetle | sawtoothed grain beetle | tropical warehouse moth | bunt (stinking smut) | cereal bunt - seed and soil bo | grain borer | seedborne flag smut | soilborne flag smut | stinking smut | ustilago hordei | ustilago nuda (tritici)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dasco proprietary limited - sodium hydroxide - liquid concentrate - sodium hydroxide mineral-sodium-base active 403.0 g/l - dairy cleanser - dairy equipment stainless steel | dairy plant stainless steel | milking equipment | building | milking machine - milkstone removal | milk fat | milk protein | mineral deposits

Singapore - English - HSA (Health Sciences Authority)

beacons pharmaceuticals pte. ltd. - liquid paraffin - emulsion - 2.5 ml/5 ml - liquid paraffin 2.5 ml/5 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: glycerol; purified water; sodium hydroxide; sorbitol solution (70 per cent) (non-crystallising); methyl hydroxybenzoate; ethanol; propyl hydroxybenzoate; sunset yellow fcf; quinoline yellow; flavour - oedema: lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical.hypertension. oral lasix may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with lasix alone.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - mercaptopurine monohydrate, quantity: 20 mg/ml - oral liquid, suspension - excipient ingredients: xanthan gum; aspartame; rubus idaeus; sodium methyl hydroxybenzoate; sodium ethyl hydroxybenzoate; potassium sorbate; sodium hydroxide; purified water - allmercap oral liquid suspension is indicated for: treatment of acute lymphoblastic leukaemia (all) in paediatric patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rotavirus, quantity: 1000000 ccid50/dose - oral liquid, suspension - excipient ingredients: sucrose; water for injections; adipic acid; sodium hydroxide; glucose monohydrate; sodium chloride; potassium chloride; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; sodium bicarbonate - rotarix is indicated for the prevention of rotavirus gastroenteritis. see section 5.1 pharmacodynamic properties - clinical trials.

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - chlorpromazine hydrochloride, quantity: 5 mg/ml - oral liquid - excipient ingredients: sucrose; caramel; peppermint oil; spearmint oil; polysorbate 20; purified water; citric acid; sodium citrate dihydrate; ascorbic acid; sodium sulfite; sodium metabisulfite; sodium benzoate; flavour - 1. treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. long-term treatment of schizophrenia. 3. short-term treatment of agitation and severe depression. 4. severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. in the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. control of intractable hiccough.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - liquid paraffin; magnesium oxide hydrated - oral emulsion - 250mg/1ml ; 60mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m loveridge ltd - liquid paraffin; magnesium oxide hydrated - oral emulsion - 250mg/1ml ; 60mg/1ml